B. G. Cooper (Birmingham, United Kingdom), I. Steenbruggen (Zwolle, The Netherlands)
Evaluation of biological quality control variance in a multi-center clinical trial for inhaled insulin
S. Blonshine, R. Harris, M. Snow (Mason, MI, Danbury, CT, St. Paul, MN, United States Of America)
|    |
Analysis of pulmonary function laboratory training needs for 39 sites in Europe and Latin America identified in an 8 to 12 hour on-site training session for an inhaled insulin trial
S. Blonshine, S. Cangiamilla, R. Harris (Mason, MI, Danbury, CT, United States Of America)
| |
Significant changes in gas transfer when upgrading lung function testing software
J. Stockley, N. John, L. Paddison, B. Cooper (Birmingham, United Kingdom)
| |
Early detection of emphysema with the nitric oxide diffusion capacity
I. van der Lee, H. Gietema, P. Zanen, M. Prokop, J. W. Lammers, J. van den Bosch (Hoofddorp, Utrecht, Nieuwegein, Netherlands)
| |
Capnovolumetry is a useful technique to detect peripheral airway obstruction
P. Reinhold, S. Reissig, J. Jaeger, A. Langenberg, H. J. Smith (Jena, Leipzig, Hoechberg, Germany)
| |
A screening classifier for obstructive sleep apnea and Cheyne-Stokes respiration
G. Weinreich, Y. M. Wang, V. Toepfer, Y. Wang, H. Teschler (Essen, Germany)
| |
Do patients with normal overnight oximetry benefit from a CPAP trial?
D. Neagu, N. Bell, R. Gibson, A. Kendrick, A. Whittle (Bristol, United Kingdom)
| |
Should an Epworth score of ≤10 exclude patients from a CPAP trial?
N. Bell, D. Neagu, R. Gibson, A. Kendrick, A. Whittle (Bristol, United Kingdom)
| |